Gilead Sciences Reached Prohost Biotech's Target
Gilead Sciences (GILD) reached our target of $120 today. Some investors will sell some and keep some and other investors will sell all the stocks they have. We will keep our stocks as we are increasing the target.

Yesterday was Gilead's announcement of its second Quarter 2025 financials. The following is what . . .